Treatment of imatinib resistant leukemia

Details Treatment of imatinib resistant leukemia Treatment of imatinib resistant leukemia

A - Human Necessities

61

K

A61K 31/4709 (2006.01) A61K 31/496 (2006.01) A61P 35/02 (2006.01)

Patent

CA 2688467

The present invention provides 4-aminoquinoline 3-carbonitirle compounds useful for treating a subject having an BcrAbl positive leukemia that is resistant to imatinib.

La présente invention concerne des composés 4-anilino-3-quinoléinecarbonitriles utiles pour le traitement d'un sujet souffrant d'une leucémie BcrAbl positive résistante à l'imatinib.

Affiliated with

Also associated with

Rating

Treatment of imatinib resistant leukemia does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of imatinib resistant leukemia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of imatinib resistant leukemia will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1572323